Detalhe da pesquisa
1.
Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.
Catheter Cardiovasc Interv
; 103(3): 417-424, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297989
2.
Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis.
Catheter Cardiovasc Interv
; 101(4): 679-686, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786485
3.
A mouth watering case of Mycoplasma salivarium native mitral valve endocarditis: 'case report'.
BMC Infect Dis
; 23(1): 81, 2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750785
4.
Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
Catheter Cardiovasc Interv
; 99(3): 523-532, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173699
5.
[COVID-19 and myocardial injury]. / Covid-19 et atteintes myocardiques.
Rev Med Suisse
; 17(728): 418-423, 2021 Mar 03.
Artigo
em Francês
| MEDLINE | ID: mdl-33656293
6.
Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials.
Eur Heart J
; 38(33): 2559-2566, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430908
7.
Ten-year clinical follow-up after sirolimus-eluting stent implantation.
Am Heart J
; 167(6): 893-9, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24890540
8.
[Diabetes mellitus and the era of telemedicine]. / Le diabète et l'ère de la télémédecine.
Rev Med Suisse
; 10(433): 1246-8, 2014 Jun 04.
Artigo
em Francês
| MEDLINE | ID: mdl-25004770
9.
Is the folk medicine known as "The Secret" efficient in reducing bleeding after percutaneous coronary procedures?: a double-blinded, randomised trial.
Open Heart
; 9(2)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539292
10.
Handheld ECG Tracking of in-hOspital Atrial Fibrillation (HECTO-AF): A Randomized Controlled Trial.
Front Cardiovasc Med
; 8: 681890, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017869
11.
Bleeding Risk Profile in Patients on Oral Anticoagulation Undergoing Percutaneous Coronary Interventions: A Prospective 24 Months Cohort Study.
Front Cardiovasc Med
; 8: 589426, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34660705
12.
Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions.
Front Cardiovasc Med
; 8: 620354, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34926595
13.
Spontaneous Recanalization of Coronary Thrombus in a Patient With Polycythemia Vera.
JACC Case Rep
; 2(3): 497-498, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34317274
14.
Impact of first medical contact to revascularisation time on long-term clinical outcomes in ST-segment elevation myocardial infarction patients.
Swiss Med Wkly
; 150: w20368, 2020 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211904
15.
Handheld ECG Tracking of in-hOspital Atrial Fibrillation The HECTO-AF trial Clinical Study Protocol.
Trials
; 20(1): 92, 2019 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700332
16.
Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial.
Open Heart
; 5(1): e000624, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29344373
17.
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials.
EuroIntervention
; 13(13): 1565-1573, 2018 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28671552
18.
Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.
JACC Cardiovasc Interv
; 11(19): 1932-1941, 2018 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249439
19.
Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials.
EuroIntervention
; 12(16): 1970-1977, 2017 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802927
20.
Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial.
Int J Cardiol
; 243: 121-125, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28576627